{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T21:57:55Z","timestamp":1791151075313,"version":"4.1.0"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2011,9,19]],"date-time":"2011-09-19T00:00:00Z","timestamp":1316390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2011,9,19]],"date-time":"2011-09-19T00:00:00Z","timestamp":1316390400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1038\/bmt.2011.178","type":"journal-article","created":{"date-parts":[[2011,9,19]],"date-time":"2011-09-19T07:07:28Z","timestamp":1316416048000},"page":"846-854","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":228,"title":["ECIL recommendations for the use of biological markers for the diagnosis of invasive fungal diseases in leukemic patients and hematopoietic SCT recipients"],"prefix":"10.1038","volume":"47","author":[{"given":"O","family":"Marchetti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Lamoth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Mikulska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Viscoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Verweij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Bretagne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"and the European Conference on Infections in Leukemia (ECIL) Laboratory Working Groups","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,9,19]]},"reference":[{"key":"BFbmt2011178_CR1","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1086\/588660","volume":"46","author":"B De Pauw","year":"2008","unstructured":"De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer\/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC\/MSG) Consensus Group. Clin Infect Dis 2008; 46: 1813\u20131821.","journal-title":"Clin Infect Dis"},{"key":"BFbmt2011178_CR2","unstructured":"ECIL. Recommendations for the use of biological markers for the diagnosis of invasive fungal infections in leukemic patients and hematopoietic stem cell transplant recipients. 2010 (http:\/\/www.ichs.org; http:\/\/www.eortc.be; http:\/\/www.ebmt.org; http:\/\/www.leukemia-net.org\/content\/home\/)."},{"key":"BFbmt2011178_CR3","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/S1473-3099(04)01045-X","volume":"4","author":"MA Mennink-Kersten","year":"2004","unstructured":"Mennink-Kersten MA, Donnelly JP, Verweij PE . Detection of circulating galactomannan for the diagnosis and management of invasive aspergillosis. Lancet Infect Dis 2004; 4: 349\u2013357.","journal-title":"Lancet Infect Dis"},{"key":"BFbmt2011178_CR4","doi-asserted-by":"crossref","unstructured":"Leeflang MM, Debets-Ossenkopp YJ, Visser CE, Scholten RJ, Hooft L, Bijlmer HA et al. Galactomannan detection for invasive aspergillosis in immunocompromised patients. Cochrane Database Syst Rev 2008: (8): CD007394.","DOI":"10.1002\/14651858.CD007394"},{"key":"BFbmt2011178_CR5","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1086\/503427","volume":"42","author":"CD Pfeiffer","year":"2006","unstructured":"Pfeiffer CD, Fine JP, Safdar N . Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis. Clin Infect Dis 2006; 42: 1417\u20131427.","journal-title":"Clin Infect Dis"},{"key":"BFbmt2011178_CR6","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1111\/j.1469-0691.2009.03065.x","volume":"16","author":"E Castagnola","year":"2010","unstructured":"Castagnola E, Furfaro E, Caviglia I, Licciardello M, Faraci M, Fioredda F et al. Performance of the galactomannan antigen detection test in the diagnosis of invasive aspergillosis in children with cancer or undergoing haemopoietic stem cell transplantation. Clin Microbiol Infect 2010; 16: 1197\u20131203.","journal-title":"Clin Microbiol Infect"},{"key":"BFbmt2011178_CR7","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1111\/j.1469-0691.2008.02122.x","volume":"15","author":"C Cordonnier","year":"2009","unstructured":"Cordonnier C, Botterel F, Ben Amor R, Pautas C, Maury S, Kuentz M et al. Correlation between galactomannan antigen levels in serum and neutrophil counts in haematological patients with invasive aspergillosis. Clin Microbiol Infect 2009; 15: 81\u201386.","journal-title":"Clin Microbiol Infect"},{"key":"BFbmt2011178_CR8","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1200\/JCO.2002.07.004","volume":"20","author":"R Herbrecht","year":"2002","unstructured":"Herbrecht R, Letscher-Bru V, Oprea C, Lioure B, Waller J, Campos F et al. Aspergillus galactomannan detection in the diagnosis of invasive aspergillosis in cancer patients. J Clin Oncol 2002; 20: 1898\u20131906.","journal-title":"J Clin Oncol"},{"key":"BFbmt2011178_CR9","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1164\/rccm.200704-606OC","volume":"177","author":"W Meersseman","year":"2008","unstructured":"Meersseman W, Lagrou K, Maertens J, Wilmer A, Hermans G, Vanderschueren S et al. Galactomannan in bronchoalveolar lavage fluid: a tool for diagnosing aspergillosis in intensive care unit patients. Am J Respir Crit Care Med 2008; 177: 27\u201334.","journal-title":"Am J Respir Crit Care Med"},{"key":"BFbmt2011178_CR10","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1086\/323335","volume":"34","author":"S Ascioglu","year":"2002","unstructured":"Ascioglu S, Rex JH, de Pauw B, Bennett JE, Bille J, Crokaert F et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 2002; 34: 7\u201314.","journal-title":"Clin Infect Dis"},{"key":"BFbmt2011178_CR11","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1086\/597395","volume":"48","author":"C Cordonnier","year":"2009","unstructured":"Cordonnier C, Pautas C, Maury S, Vekhoff A, Farhat H, Suarez F et al. Empirical versus preemptive antifungal therapy for high-risk, febrile, neutropenic patients: a randomized, controlled trial. Clin Infect Dis 2009; 48: 1042\u20131051.","journal-title":"Clin Infect Dis"},{"key":"BFbmt2011178_CR12","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1086\/496927","volume":"41","author":"J Maertens","year":"2005","unstructured":"Maertens J, Theunissen K, Verhoef G, Verschakelen J, Lagrou K, Verbeken E et al. Galactomannan and computed tomography-based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: a prospective feasibility study. Clin Infect Dis 2005; 41: 1242\u20131250.","journal-title":"Clin Infect Dis"},{"key":"BFbmt2011178_CR13","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1086\/514349","volume":"44","author":"JA Maertens","year":"2007","unstructured":"Maertens JA, Klont R, Masson C, Theunissen K, Meersseman W, Lagrou K et al. Optimization of the cutoff value for the Aspergillus double-sandwich enzyme immunoassay. Clin Infect Dis 2007; 44: 1329\u20131336.","journal-title":"Clin Infect Dis"},{"key":"BFbmt2011178_CR14","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1128\/JCM.02281-09","volume":"48","author":"S Koo","year":"2010","unstructured":"Koo S, Bryar JM, Baden LR, Marty FM . Prognostic features of galactomannan antigenemia in galactomannan-positive invasive aspergillosis. J Clin Microbiol 2010; 48: 1255\u20131260.","journal-title":"J Clin Microbiol"},{"key":"BFbmt2011178_CR15","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1086\/647935","volume":"49","author":"J Maertens","year":"2009","unstructured":"Maertens J, Maertens V, Theunissen K, Meersseman W, Meersseman P, Meers S et al. Bronchoalveolar lavage fluid galactomannan for the diagnosis of invasive pulmonary aspergillosis in patients with hematologic diseases. Clin Infect Dis 2009; 49: 1688\u20131693.","journal-title":"Clin Infect Dis"},{"key":"BFbmt2011178_CR16","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1086\/429921","volume":"40","author":"KA Marr","year":"2005","unstructured":"Marr KA, Laverdiere M, Gugel A, Leisenring W . Antifungal therapy decreases sensitivity of the Aspergillus galactomannan enzyme immunoassay. Clin Infect Dis 2005; 40: 1762\u20131769.","journal-title":"Clin Infect Dis"},{"key":"BFbmt2011178_CR17","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1099\/jmm.0.47479-0","volume":"57","author":"M Ellis","year":"2008","unstructured":"Ellis M, Al-Ramadi B, Finkelman M, Hedstrom U, Kristensen J, Ali-Zadeh H et al. Assessment of the clinical utility of serial beta-D-glucan concentrations in patients with persistent neutropenic fever. J Med Microbiol 2008; 57: 287\u2013295.","journal-title":"J Med Microbiol"},{"key":"BFbmt2011178_CR18","first-page":"745","volume":"85","author":"M Kami","year":"2000","unstructured":"Kami M, Tanaka Y, Kanda Y, Ogawa S, Masumoto T, Ohtomo K et al. Computed tomographic scan of the chest, latex agglutination test and plasma (1AE3)-beta-D-glucan assay in early diagnosis of invasive pulmonary aspergillosis: a prospective study of 215 patients. Haematologica 2000; 85: 745\u2013752.","journal-title":"Haematologica"},{"key":"BFbmt2011178_CR19","doi-asserted-by":"publisher","first-page":"2733","DOI":"10.1128\/JCM.42.6.2733-2741.2004","volume":"42","author":"M Kawazu","year":"2004","unstructured":"Kawazu M, Kanda Y, Nannya Y, Aoki K, Kurokawa M, Chiba S et al. Prospective comparison of the diagnostic potential of real-time PCR, double-sandwich enzyme-linked immunosorbent assay for galactomannan, and a (1 \u2192 3)-beta-D-glucan test in weekly screening for invasive aspergillosis in patients with hematological disorders. J Clin Microbiol 2004; 42: 2733\u20132741.","journal-title":"J Clin Microbiol"},{"key":"BFbmt2011178_CR20","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1086\/647942","volume":"49","author":"S Koo","year":"2009","unstructured":"Koo S, Bryar JM, Page JH, Baden LR, Marty FM . Diagnostic performance of the (1 \u2192 3)-beta-D-glucan assay for invasive fungal disease. Clin Infect Dis 2009; 49: 1650\u20131659.","journal-title":"Clin Infect Dis"},{"key":"BFbmt2011178_CR21","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1086\/588295","volume":"46","author":"T Obayashi","year":"2008","unstructured":"Obayashi T, Negishi K, Suzuki T, Funata N . Reappraisal of the serum (1 \u2192 3)-beta-D-glucan assay for the diagnosis of invasive fungal infections--a study based on autopsy cases from 6 years. Clin Infect Dis 2008; 46: 1864\u20131870.","journal-title":"Clin Infect Dis"},{"key":"BFbmt2011178_CR22","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/S0140-6736(95)91152-9","volume":"345","author":"T Obayashi","year":"1995","unstructured":"Obayashi T, Yoshida M, Mori T, Goto H, Yasuoka A, Iwasaki H et al. Plasma (1 \u2192 3)-beta-D-glucan measurement in diagnosis of invasive deep mycosis and fungal febrile episodes. Lancet 1995; 345: 17\u201320.","journal-title":"Lancet"},{"key":"BFbmt2011178_CR23","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1086\/421944","volume":"39","author":"Z Odabasi","year":"2004","unstructured":"Odabasi Z, Mattiuzzi G, Estey E, Kantarjian H, Saeki F, Ridge RJ et al. Beta-D-glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome. Clin Infect Dis 2004; 39: 199\u2013205.","journal-title":"Clin Infect Dis"},{"key":"BFbmt2011178_CR24","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1086\/432470","volume":"41","author":"L Ostrosky-Zeichner","year":"2005","unstructured":"Ostrosky-Zeichner L, Alexander BD, Kett DH, Vazquez J, Pappas PG, Saeki F et al. Multicenter clinical evaluation of the (1 \u2192 3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans. Clin Infect Dis 2005; 41: 654\u2013659.","journal-title":"Clin Infect Dis"},{"key":"BFbmt2011178_CR25","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1128\/JCM.02091-07","volume":"46","author":"F Persat","year":"2008","unstructured":"Persat F, Ranque S, Derouin F, Michel-Nguyen A, Picot S, Sulahian A . Contribution of the (1 \u2192 3)-beta-D-glucan assay for diagnosis of invasive fungal infections. J Clin Microbiol 2008; 46: 1009\u20131013.","journal-title":"J Clin Microbiol"},{"key":"BFbmt2011178_CR26","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1086\/527382","volume":"46","author":"L Senn","year":"2008","unstructured":"Senn L, Robinson JO, Schmidt S, Knaup M, Asahi N, Satomura S et al. 1,3-Beta-D-glucan antigenemia for early diagnosis of invasive fungal infections in neutropenic patients with acute leukemia. Clin Infect Dis 2008; 46: 878\u2013885.","journal-title":"Clin Infect Dis"},{"key":"BFbmt2011178_CR27","doi-asserted-by":"crossref","unstructured":"Lamoth F, Cruciani M, Mengoli C, Castagnola E, Lortholary O, Richardson M et al. Beta-glucan antigenemia for the diagnosis of invasive fungal infections in patients with hematological malignancies: systematic review and meta-analysis of cohort studies. Clin Infect Dis 2011 (accepted).","DOI":"10.1093\/cid\/cir897"},{"key":"BFbmt2011178_CR28","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1080\/13693780802607400","volume":"47","author":"NE Babady","year":"2009","unstructured":"Babady NE, Bestrom JE, Jespersen DJ, Jones MF, Beito EM, Binnicker MJ et al. Evaluation of three commercial latex agglutination kits and a commercial enzyme immunoassay for the detection of cryptococcal antigen. Med Mycol 2009; 47: 336\u2013338.","journal-title":"Med Mycol"},{"key":"BFbmt2011178_CR29","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.idc.2006.07.001","volume":"20","author":"M Chayakulkeeree","year":"2006","unstructured":"Chayakulkeeree M, Perfect JR . Cryptococcosis. Infect Dis Clin North Am 2006; 20: 507\u2013544.","journal-title":"Infect Dis Clin North Am"},{"key":"BFbmt2011178_CR30","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1007\/s100960100616","volume":"20","author":"S Antinori","year":"2001","unstructured":"Antinori S, Galimberti L, Magni C, Casella A, Vago L, Mainini F et al. Cryptococcus neoformans infection in a cohort of Italian AIDS patients: natural history, early prognostic parameters, and autopsy findings. Eur J Clin Microbiol Infect Dis 2001; 20: 711\u2013717.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"BFbmt2011178_CR31","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s10096-007-0430-1","volume":"27","author":"YM Chuang","year":"2008","unstructured":"Chuang YM, Ho YC, Chang HT, Yu CJ, Yang PC, Hsueh PR . Disseminated cryptococcosis in HIV-uninfected patients. Eur J Clin Microbiol Infect Dis 2008; 27: 307\u2013310.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"BFbmt2011178_CR32","doi-asserted-by":"publisher","first-page":"e21","DOI":"10.1371\/journal.pmed.0040021","volume":"4","author":"F Dromer","year":"2007","unstructured":"Dromer F, Mathoulin-Pelissier S, Launay O, Lortholary O . Determinants of disease presentation and outcome during cryptococcosis: the CryptoA\/D study. PLoS Med 2007; 4: e21.","journal-title":"PLoS Med"},{"key":"BFbmt2011178_CR33","doi-asserted-by":"publisher","first-page":"375","DOI":"10.3201\/eid0703.017302","volume":"7","author":"S Husain","year":"2001","unstructured":"Husain S, Wagener MM, Singh N . Cryptococcus neoformans infection in organ transplant recipients: variables influencing clinical characteristics and outcome. Emerg Infect Dis 2001; 7: 375\u2013381.","journal-title":"Emerg Infect Dis"},{"key":"BFbmt2011178_CR34","doi-asserted-by":"crossref","first-page":"111","DOI":"10.7883\/yoken.JJID.2008.111","volume":"61","author":"U Jongwutiwes","year":"2008","unstructured":"Jongwutiwes U, Sungkanuparph S, Kiertiburanakul S . Comparison of clinical features and survival between cryptococcosis in human immunodeficiency virus (HIV)-positive and HIV-negative patients. Jpn J Infect Dis 2008; 61: 111\u2013115.","journal-title":"Jpn J Infect Dis"},{"key":"BFbmt2011178_CR35","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1086\/322597","volume":"33","author":"PG Pappas","year":"2001","unstructured":"Pappas PG, Perfect JR, Cloud GA, Larsen RA, Pankey GA, Lancaster DJ et al. Cryptococcosis in human immunodeficiency virus-negative patients in the era of effective azole therapy. Clin Infect Dis 2001; 33: 690\u2013699.","journal-title":"Clin Infect Dis"},{"key":"BFbmt2011178_CR36","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1111\/j.1432-2277.2003.tb00309.x","volume":"16","author":"R Vilchez","year":"2003","unstructured":"Vilchez R, Shapiro R, McCurry K, Kormos R, Abu-Elmagd K, Fung J et al. Longitudinal study of cryptococcosis in adult solid-organ transplant recipients. Transpl Int 2003; 16: 336\u2013340.","journal-title":"Transpl Int"},{"key":"BFbmt2011178_CR37","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1093\/ajcp\/109.5.634","volume":"109","author":"DL Jaye","year":"1998","unstructured":"Jaye DL, Waites KB, Parker B, Bragg SL, Moser SA . Comparison of two rapid latex agglutination tests for detection of cryptococcal capsular polysaccharide. Am J Clin Pathol 1998; 109: 634\u2013641.","journal-title":"Am J Clin Pathol"},{"key":"BFbmt2011178_CR38","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1128\/jcm.32.7.1680-1684.1994","volume":"32","author":"DC Tanner","year":"1994","unstructured":"Tanner DC, Weinstein MP, Fedorciw B, Joho KL, Thorpe JJ, Reller L . Comparison of commercial kits for detection of cryptococcal antigen. J Clin Microbiol 1994; 32: 1680\u20131684.","journal-title":"J Clin Microbiol"},{"key":"BFbmt2011178_CR39","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1046\/j.1439-0507.2003.00877.x","volume":"46","author":"DP Kontoyiannis","year":"2003","unstructured":"Kontoyiannis DP . What is the significance of an isolated positive cryptococcal antigen in the cerebrospinal fluid of cancer patients? Mycoses 2003; 46: 161\u2013163.","journal-title":"Mycoses"},{"key":"BFbmt2011178_CR40","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1002\/yea.320100702","volume":"10","author":"FM Klis","year":"1994","unstructured":"Klis FM . Review: cell wall assembly in yeast. Yeast 1994; 10: 851\u2013869.","journal-title":"Yeast"},{"key":"BFbmt2011178_CR41","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1111\/j.1574-6968.1998.tb13309.x","volume":"169","author":"PM Jacquinot","year":"1998","unstructured":"Jacquinot PM, Plancke Y, Sendid B, Strecker G, Poulain D . Nature of Candida albicans-derived carbohydrate antigen recognized by a monoclonal antibody in patient sera and distribution over Candida species. FEMS Microbiol Lett 1998; 169: 131\u2013138.","journal-title":"FEMS Microbiol Lett"},{"key":"BFbmt2011178_CR42","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1128\/JCM.37.5.1510-1517.1999","volume":"37","author":"B Sendid","year":"1999","unstructured":"Sendid B, Tabouret M, Poirot JL, Mathieu D, Fruit J, Poulain D . New enzyme immunoassays for sensitive detection of circulating Candida albicans mannan and antimannan antibodies: useful combined test for diagnosis of systemic candidiasis. J Clin Microbiol 1999; 37: 1510\u20131517.","journal-title":"J Clin Microbiol"},{"key":"BFbmt2011178_CR43","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/1471-2334-7-103","volume":"7","author":"FF Alam","year":"2007","unstructured":"Alam FF, Mustafa AS, Khan ZU . Comparative evaluation of (1, 3)-beta-D-glucan, mannan and anti-mannan antibodies, and Candida species-specific snPCR in patients with candidemia. BMC Infect Dis 2007; 7: 103.","journal-title":"BMC Infect Dis"},{"key":"BFbmt2011178_CR44","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1099\/jmm.0.006452-0","volume":"58","author":"M Ellis","year":"2009","unstructured":"Ellis M, Al-Ramadi B, Bernsen R, Kristensen J, Alizadeh H, Hedstrom U . Prospective evaluation of mannan and anti-mannan antibodies for diagnosis of invasive Candida infections in patients with neutropenic fever. J Med Microbiol 2009; 58: 606\u2013615.","journal-title":"J Med Microbiol"},{"key":"BFbmt2011178_CR45","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1099\/jmm.0.46314-0","volume":"55","author":"S Fujita","year":"2006","unstructured":"Fujita S, Takamura T, Nagahara M, Hashimoto T . Evaluation of a newly developed down-flow immunoassay for detection of serum mannan antigens in patients with candidaemia. J Med Microbiol 2006; 55: 537\u2013543.","journal-title":"J Med Microbiol"},{"key":"BFbmt2011178_CR46","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1111\/j.1469-0691.2007.01938.x","volume":"14","author":"S Oliveri","year":"2008","unstructured":"Oliveri S, Trovato L, Betta P, Romeo MG, Nicoletti G . Experience with the Platelia Candida ELISA for the diagnosis of invasive candidosis in neonatal patients. Clin Microbiol Infect 2008; 14: 391\u2013393.","journal-title":"Clin Microbiol Infect"},{"key":"BFbmt2011178_CR47","first-page":"455","volume":"45","author":"F Persat","year":"2002","unstructured":"Persat F, Topenot R, Piens MA, Thiebaut A, Dannaoui E, Picot S . Evaluation of different commercial ELISA methods for the serodiagnosis of systemic candidosis. Mycoses 2002; 45: 455\u2013460.","journal-title":"Mycoses"},{"key":"BFbmt2011178_CR48","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.diagmicrobio.2004.08.015","volume":"51","author":"M Prella","year":"2005","unstructured":"Prella M, Bille J, Pugnale M, Duvoisin B, Cavassini M, Calandra T et al. Early diagnosis of invasive candidiasis with mannan antigenemia and antimannan antibodies. Diagn Microbiol Infect Dis 2005; 51: 95\u2013101.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"BFbmt2011178_CR49","doi-asserted-by":"publisher","first-page":"4551","DOI":"10.1128\/JCM.41.10.4551-4558.2003","volume":"41","author":"B Sendid","year":"2003","unstructured":"Sendid B, Caillot D, Baccouch-Humbert B, Klingspor L, Grandjean M, Bonnin A et al. Contribution of the Platelia Candida-specific antibody and antigen tests to early diagnosis of systemic Candida tropicalis infection in neutropenic adults. J Clin Microbiol 2003; 41: 4551\u20134558.","journal-title":"J Clin Microbiol"},{"key":"BFbmt2011178_CR50","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1128\/CVI.00200-08","volume":"15","author":"B Sendid","year":"2008","unstructured":"Sendid B, Dotan N, Nseir S, Savaux C, Vandewalle P, Standaert A et al. Antibodies against glucan, chitin, and Saccharomyces cerevisiae mannan as new biomarkers of Candida albicans infection that complement tests based on C. albicans mannan. Clin Vaccine Immunol 2008; 15: 1868\u20131877.","journal-title":"Clin Vaccine Immunol"},{"key":"BFbmt2011178_CR51","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1128\/JCM.42.1.164-171.2004","volume":"42","author":"B Sendid","year":"2004","unstructured":"Sendid B, Jouault T, Coudriau R, Camus D, Odds F, Tabouret M et al. Increased sensitivity of mannanemia detection tests by joint detection of alpha- and beta-linked oligomannosides during experimental and human systemic candidiasis. J Clin Microbiol 2004; 42: 164\u2013171.","journal-title":"J Clin Microbiol"},{"key":"BFbmt2011178_CR52","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1099\/0022-1317-51-5-433","volume":"51","author":"B Sendid","year":"2002","unstructured":"Sendid B, Poirot JL, Tabouret M, Bonnin A, Caillot D, Camus D et al. Combined detection of mannanaemia and antimannan antibodies as a strategy for the diagnosis of systemic infection caused by pathogenic Candida species. J Med Microbiol 2002; 51: 433\u2013442.","journal-title":"J Med Microbiol"},{"key":"BFbmt2011178_CR53","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1111\/j.1469-0691.2008.02654.x","volume":"15","author":"FM Verduyn Lunel","year":"2009","unstructured":"Verduyn Lunel FM, Donnelly JP, van der Lee HA, Blijlevens NM, Verweij PE . Circulating Candida-specific anti-mannan antibodies precede invasive candidiasis in patients undergoing myelo-ablative chemotherapy. Clin Microbiol Infect 2009; 15: 380\u2013386.","journal-title":"Clin Microbiol Infect"},{"key":"BFbmt2011178_CR54","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1128\/JCM.43.5.2181-2187.2005","volume":"43","author":"PL White","year":"2005","unstructured":"White PL, Archer AE, Barnes RA . Comparison of non-culture-based methods for detection of systemic fungal infections, with an emphasis on invasive Candida infections. J Clin Microbiol 2005; 43: 2181\u20132187.","journal-title":"J Clin Microbiol"},{"key":"BFbmt2011178_CR55","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1007\/s100960100629","volume":"20","author":"H Yera","year":"2001","unstructured":"Yera H, Sendid B, Francois N, Camus D, Poulain D . Contribution of serological tests and blood culture to the early diagnosis of systemic candidiasis. Eur J Clin Microbiol Infect Dis 2001; 20: 864\u2013870.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"BFbmt2011178_CR56","doi-asserted-by":"publisher","first-page":"R222","DOI":"10.1186\/cc9365","volume":"14","author":"M Mikulska","year":"2010","unstructured":"Mikulska M, Calandra T, Sanguinetti M, Poulain D, Viscoli C . Mannan antigen and anti-mannan antibodies in the diagnosis of invasive candidiasis: recommendations from the third European Conference on Infections in Leukemia. Crit Care 2010; 14: R222.","journal-title":"Crit Care"},{"key":"BFbmt2011178_CR57","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.femsim.2005.05.012","volume":"45","author":"S Bretagne","year":"2005","unstructured":"Bretagne S, Costa JM . Towards a molecular diagnosis of invasive aspergillosis and disseminated candidosis. FEMS Immunol Med Microbiol 2005; 45: 361\u2013368.","journal-title":"FEMS Immunol Med Microbiol"},{"key":"BFbmt2011178_CR58","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1373\/clinchem.2008.112797","volume":"55","author":"SA Bustin","year":"2009","unstructured":"Bustin SA, Benes V, Garson JA, Hellemans J, Huggett J, Kubista M et al. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem 2009; 55: 611\u2013622.","journal-title":"Clin Chem"},{"key":"BFbmt2011178_CR59","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1007\/s11908-010-0139-7","volume":"12","author":"S Bretagne","year":"2011","unstructured":"Bretagne S . Advances and prospects for molecular diagnostics of fungal infections. Curr Infect Dis Rep 2011; 12: 430\u2013436.","journal-title":"Curr Infect Dis Rep"},{"key":"BFbmt2011178_CR60","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/S1473-3099(09)70019-2","volume":"9","author":"C Mengoli","year":"2009","unstructured":"Mengoli C, Cruciani M, Barnes RA, Loeffler J, Donnelly JP . Use of PCR for diagnosis of invasive aspergillosis: systematic review and meta-analysis. Lancet Infect Dis 2009; 9: 89\u201396.","journal-title":"Lancet Infect Dis"},{"key":"BFbmt2011178_CR61","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1136\/jcp.2008.058354","volume":"62","author":"RA Barnes","year":"2009","unstructured":"Barnes RA, White PL, Bygrave C, Evans N, Healy B, Kell J . Clinical impact of enhanced diagnosis of invasive fungal disease in high-risk haematology and stem cell transplant patients. J Clin Pathol 2009; 62: 64\u201369.","journal-title":"J Clin Pathol"},{"key":"BFbmt2011178_CR62","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/bmt.2008.355","volume":"43","author":"H Hebart","year":"2009","unstructured":"Hebart H, Klingspor L, Klingebiel T, Loeffler J, Tollemar J, Ljungman P et al. A prospective randomized controlled trial comparing PCR-based and empirical treatment with liposomal amphotericin B in patients after allo-SCT. Bone Marrow Transplant 2009; 43: 553\u2013561.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2011178_CR63","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/S1130-1406(07)70020-7","volume":"24","author":"FF Tuon","year":"2007","unstructured":"Tuon FF . A systematic literature review on the diagnosis of invasive aspergillosis using polymerase chain reaction (PCR) from bronchoalveolar lavage clinical samples. Rev Iberoam Micol 2007; 24: 89\u201394.","journal-title":"Rev Iberoam Micol"},{"key":"BFbmt2011178_CR64","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1128\/JCM.01767-09","volume":"48","author":"PL White","year":"2010","unstructured":"White PL, Bretagne S, Klingspor L, Melchers WJ, McCulloch E, Schulz B et al. Aspergillus PCR: one step closer to standardization. J Clin Microbiol 2010; 48: 1231\u20131240.","journal-title":"J Clin Microbiol"},{"key":"BFbmt2011178_CR65","doi-asserted-by":"publisher","first-page":"3753","DOI":"10.1128\/JCM.01466-10","volume":"48","author":"PL White","year":"2010","unstructured":"White PL, Perry MD, Loeffler J, Melchers W, Klingspor L, Bretagne S et al. The critical stages of extracting DNA from Aspergillus fumigatus in whole blood specimens. J Clin Microbiol 2010; 48: 3753\u20133755.","journal-title":"J Clin Microbiol"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/bmt2011178.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2011178","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2011178.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,9]],"date-time":"2023-06-09T15:03:44Z","timestamp":1686323024000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bmt2011178"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9,19]]},"references-count":65,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["BFbmt2011178"],"URL":"https:\/\/doi.org\/10.1038\/bmt.2011.178","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,9,19]]},"assertion":[{"value":"23 March 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2011","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2011","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2011","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Oscar Marchetti received unrestricted research grants and\/or educational grants and\/or speaker's honoraria and\/or consultant's honoraria from the Foundation for the Advancement in Medical Microbiology and Infectious Diseases, FAMMID, Lausanne, Switzerland, Associates of Cape Code, BioM\u00e9rieux\u2014Cepheid, Bio-Rad, Wako, and Roche Diagnostics. St\u00e9phane Bretagne received consultant's honoraria from Myconostica. The remaining authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}